BioCardia, Inc. (BCDA)
Total Valuation
BioCardia has a market cap or net worth of $41.69 million. The enterprise value is $36.73 million.
| Market Cap | 41.69M |
| Enterprise Value | 36.73M |
Important Dates
The next earnings date is Tuesday, May 9, 2023, after market close.
| Estimated Earnings Date | May 9, 2023 |
| Ex-Dividend Date | n/a |
Share Statistics
BioCardia has 20.05 million shares outstanding. The number of shares has increased by 4.56% in one year.
| Shares Outstanding | 20.05M |
| Shares Change (YoY) | +4.56% |
| Shares Change (QoQ) | +1.09% |
| Owned by Insiders (%) | 33.25% |
| Owned by Institutions (%) | 17.96% |
| Float | 11.29M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 31.47 |
| Forward PS | 1,135.47 |
| PB Ratio | 10.18 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 27.72 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.94, with a Debt / Equity ratio of 0.42.
| Current Ratio | 1.94 |
| Quick Ratio | 1.89 |
| Debt / Equity | 0.42 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
Financial Efficiency
Return on equity (ROE) is -172.70% and return on invested capital (ROIC) is -1,321.20%.
| Return on Equity (ROE) | -172.70% |
| Return on Assets (ROA) | -100.70% |
| Return on Capital (ROIC) | -1,321.20% |
| Revenue Per Employee | $47,321 |
| Profits Per Employee | -$440,714 |
| Employee Count | 28 |
| Asset Turnover | 0.11 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -2.09% in the last 52 weeks. The beta is 1.07, so BioCardia's price volatility has been similar to the market average.
| Beta (1Y) | 1.07 |
| 52-Week Price Change | -2.09% |
| 50-Day Moving Average | 2.22 |
| 200-Day Moving Average | 1.90 |
| Average Volume (30 Days) | 31,111 |
Short Selling Information
The latest short interest is 37,538, so 0.19% of the outstanding shares have been sold short.
| Short Interest | 37,538 |
| Short Previous Month | 35,811 |
| Short % of Shares Out | 0.19% |
| Short % of Float | 0.33% |
| Short Ratio (days to cover) | 1.58 |
Income Statement
In the last 12 months, BioCardia had revenue of $1.33 million and -$12.34 million in losses. Loss per share was -$0.71.
| Revenue | 1.33M |
| Gross Profit | 1.33M |
| Operating Income | -12.34M |
| Pretax Income | -12.34M |
| Net Income | -12.34M |
| EBITDA | -12.46M |
| EBIT | -12.34M |
| Loss Per Share | -$0.71 |
Balance Sheet
The company has $6.67 million in cash and $1.70 million in debt, giving a net cash position of $4.97 million or $0.25 per share.
| Cash & Cash Equivalents | 6.67M |
| Total Debt | 1.70M |
| Net Cash | 4.97M |
| Net Cash Per Share | $0.25 |
| Equity / Book Value | 4.10M |
| Book Value Per Share | 0.20 |
| Working Capital | 3.47M |
Cash Flow
In the last 12 months, operating cash flow was -$10.54 million and capital expenditures -$109,000, giving a free cash flow of -$10.65 million.
| Operating Cash Flow | -10.54M |
| Capital Expenditures | -109,000 |
| Free Cash Flow | -10.65M |
| FCF Per Share | -$0.60 |
Margins
Gross margin is 100.00%, with operating and profit margins of -931.62% and -931.32%.
| Gross Margin | 100.00% |
| Operating Margin | -931.62% |
| Pretax Margin | -931.32% |
| Profit Margin | -931.32% |
| EBITDA Margin | -940.60% |
| EBIT Margin | -931.32% |
| FCF Margin | -803.62% |
Dividends & Yields
BioCardia does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -29.60% |
| FCF Yield | -25.54% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.56% |
| Shareholder Yield | -4.56% |
Analyst Forecast
The average price target for BioCardia is $7.65, which is 271.36% higher than the current price. The consensus rating is "Buy".
| Price Target | $7.65 |
| Price Target Difference | 271.36% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 73.13% |
| EPS Growth Forecast (5Y) | -12.06% |
Stock Splits
The last stock split was on June 6, 2019. It was a reverse split with a ratio of 1:9.
| Last Split Date | Jun 6, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:9 |